Acadia Pharmaceuticals

ACAD

37.59

-0.04

-0.1%

After Hours:

37.31

-0.28

-0.7%

Please Login or Register

Login|Register FREE

Stock Price
Open: 37.66
Prev. Close: 37.63
Low/Hi: 37.30 - 37.89
52-Week: 20.68 - 40.83
Volumes
Equity: 867,143
90-Day Avg: 1,458,472
Option: 887
90-Day Avg: 1,627
Volatility
Todays Stock Vol: 16.6
20-Day (HV): 35.8
52-Week (HV): 49.8
30-Day IV: 40.0 -0.7
IV Pct Rank: 0% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 7-Nov (Est.)
P/E Ratio:
Market Cap: 4.6 B
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACAD Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income -36,966 -87,843 -78,696 -71,613
Change in Working Capital -10,195 1,085 111 7,364
Depreciation Amortization Depletion and Accretion 492 526 574 978
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 18,244 15,571 14,822 14,009
Total Cash from Operating Activities -58,900 -70,661 -63,189 -49,262
Capital Expenditures -264 -485 -249 -470
Other Investing Cash Flow 38,563 53,420 69,389 -154,438
Total Cash from Investing Activities 38,299 52,935 69,140 -154,908
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 7,010 11,490 3,390 226,077
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 0 596 0
Total Cash from Financing Activities 7,010 11,490 3,986 226,077
Exchange Rate Effects -3 -1 4 -2
Net Change in Cash -13,594 -6,237 9,941 21,905
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -271,393 -164,443 -92,475 -37,948
Change in Working Capital 4,394 4,114 9,312 -1,129
Depreciation Amortization Depletion and Accretion 1,917 -1,413 690 1,607
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 54,674 39,947 16,039 5,701
Total Cash from Operating Activities -210,408 -121,795 -66,434 -31,769
Capital Expenditures -9,506 -2,141 -180 -618
Other Investing Cash Flow -252,418 149,711 -87,093 -125,486
Total Cash from Investing Activities -261,924 147,570 -87,273 -126,104
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 533,216 14,547 203,851 111,682
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 596 -45 0 0
Total Cash from Financing Activities 533,812 14,502 203,851 111,682
Exchange Rate Effects 2 7 3 -1
Net Change in Cash 61,482 40,284 50,147 -46,192